In vitro activation of 7-benzyloxyresorufin O-debenzylation and nifedipine oxidation in human liver microsomes

Abstract

1. The effects of substrate concentration and enzyme source (human liver microsomes and recombinant cytochrome P450s, CYP) on the activation of 7-benzyloxyresorufin O-debenzylation and nifedipine oxidation were investigated.2. 7-Benzyloxyresorufin O-debenzylase activity in human liver microsomes was inhibited by a monoclonal antibody against CYP2B6 and a polyclonal antibody against CYP3A2 by 53–69 and 19–44%, respectively, suggesting that CYP2B6 and CYP3A4 mainly catalyse 7-benzyloxyresofurin O-debenzylation in human liver microsomes.3. 7-Benzyloxyresorufin O-debenzylase activity at 0.2–5 µM substrate concentrations in human liver microsomes was increased by the addition of α-naphthoflavone, quinidine, testosterone and progesterone, and the Vmax of 7-benzyloxyresorufin O-debenzylation increased with increasing α-naphthoflavone concentrations, whereas the Km remained constant. Additionally, 7-benzyloxyresorufin O-debenzylation by recombinant CYP3A4 was increased by the addition by the addition of α-naphthoflavone, testosterone and progesterone but not by quinidine, whereas no chemicals tested could activate the O-debenzylation of 7-benzyloxyresorufin by CYP2B6.4. The Km for nifedipine oxidation by CYP3A4 decreased by the addition of progesterone, whereas the Vmax remained constant. Quinidine and testosterone increased 7-Benzyloxyresorufin O-debenzylase and nifedipine oxidase activities, respectively, in human liver microsomes, whereas activation was not observed in CYP3A4.5. The results suggest that in vitro activation patterns are substrate dependent and that selection of the enzyme source can influence the activation phenomenom.